Hippuric Acid → HCID 86646675, compound
Reaction equation
[C:1]([OH:7])([C:3]([F:6])([F:5])[F:4])=[O:2].CCN=C=NCCCN(C)C.[C:19]([OH:31])(=O)[CH2:20][NH:21][C:22]([C:24]1[CH:29]=[CH:28][CH:27]=[CH:26][CH:25]=1)=[O:23].C(OC([N:39]1[CH2:42][CH:41]([NH2:43])[CH2:40]1)=O)(C)(C)C>>[OH:7][C:1]([C:3]([F:6])([F:5])[F:4])=[O:2].[NH:39]1[CH2:42][CH:41]([NH:43][C:19]([CH2:20][NH:21][C:22](=[O:23])[C:24]2[CH:25]=[CH:26][CH:27]=[CH:28][CH:29]=2)=[O:31])[CH2:40]1Participants
5
Procedure
The title compound was prepared as a TFA salt from the EDCI coupling of hippuric acid (Fluka) and 3-amino-azetidine-1-carboxylic acid tert-butyl ester (BetaPharm) followed by the de-protection of N-Boc by TFA using the procedures described in Example 1, steps D and E.
Sources & evidence
- ORD record
- ord-3408af5fbf6448bebc41521359bdf618
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08269015B2
Reaction notes
Loading…